Restriction spectrum imaging improves MRI-based prostate cancer detection.

Abstract

To compare the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. Three readers independently evaluated 100 patients (67 with proven PCa) who underwent MP-MRI and RSI within 6months of systematic biopsy (N=67; 23 with targeting performed) or prostatectomy (N=33). Imaging was performed at 3Tesla using a phased-array coil. Readers used a five-point scale estimating the likelihood of PCa present in each prostate sextant. Evaluation was performed in two separate sessions, first using conventional MP-MRI alone then immediately with MP-MRI and RSI in the same session. Fourweeks later, another scoring session used RSI and T2-weighted imaging (T2WI) without conventional diffusion-weighted or dynamic contrast-enhanced imaging. Reader interpretations were then compared to prostatectomy data or biopsy results. Receiver operating characteristic curves were performed, with area under the curve (AUC) used to compare across groups. MP-MRI with RSI achieved higher AUCs compared to MP-MRI alone for identifying high-grade (Gleason score greater than or equal to 4+3=7) PCa (0.78 vs. 0.70 at the sextant level; P<0.001 and 0.85 vs. 0.79 at the hemigland level; P=0.04). RSI and T2WI alone achieved AUCs similar to MP-MRI for high-grade PCa (0.71 vs. 0.70 at the sextant level). With hemigland analysis, high-grade disease results were similar when comparing RSI+T2WI with MP-MRI, although with greater AUCs compared to the sextant analysis (0.80 vs. 0.79). Including RSI with MP-MRI improves PCa detection compared to MP-MRI alone, and RSI with T2WI achieves similar PCa detection as MP-MRI.